{"gene":"TGFBRAP1","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":1998,"finding":"TGFBRAP1 (TRAP-1) was identified as a novel protein that selectively interacts with the activated (but not quiescent) form of type I TGF-β receptor (TbetaR-I). In yeast two-hybrid and mammalian co-precipitation assays, TRAP-1 bound constitutively active (L193A/P194A/T204D) and ligand-activated TbetaR-I but not wild-type TbetaR-I in the absence of TGF-β. A partial TRAP-1 construct inhibited TGF-β signaling as measured by a TGF-β-dependent reporter gene.","method":"Yeast two-hybrid screen with activated TbetaR-I bait; co-immunoprecipitation in mammalian cells; TGF-β reporter gene assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP in yeast and mammalian cells, functional reporter assay, Moderate evidence from single lab with multiple orthogonal methods","pmids":["9545258"],"is_preprint":false},{"year":1999,"finding":"TGFBRAP1 (TGF-β receptor-I-associated protein 1) was identified as an interactor of 5-lipoxygenase (5-LO) in a yeast two-hybrid screen of a human lung cDNA library, suggesting a potential link between TGF-β receptor signaling and leukotriene synthesis pathways.","method":"Yeast two-hybrid screen","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Low","confidence_rationale":"Tier 3 — single yeast two-hybrid result, no follow-up validation of the 5-LO/TGFBRAP1 interaction","pmids":["10051563"],"is_preprint":false},{"year":2001,"finding":"TGFBRAP1 (TRAP1) was shown to function as a molecular chaperone for Smad4 in TGF-β signaling. TRAP1 associates with inactive heteromeric TGF-β and activin receptor complexes and is released upon receptor activation. In a ligand-dependent fashion, TRAP1 interacts with Smad4 (the common mediator Smad). Deletion constructs of TRAP1 inhibit TGF-β signaling and diminish the Smad4–Smad2 interaction, consistent with a model in which TRAP1 escorts Smad4 to the activated receptor complex to facilitate its transfer to receptor-activated Smads.","method":"Co-immunoprecipitation; deletion mutant functional analysis; TGF-β signaling reporter assays; fluorescence resonance energy transfer (FRET)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (Co-IP, dominant-negative deletion mutants, reporter assays, FRET), Moderate evidence from single lab","pmids":["11278302"],"is_preprint":false},{"year":2010,"finding":"TGFBRAP1 (TRAP1) is essential for early embryonic development. Mice with homozygous deletion of TRAP1 die at two defined timepoints: before the blastula stage or during gastrulation, demonstrating a non-redundant requirement for TRAP1 in embryogenesis. Heterozygous mice are phenotypically normal.","method":"Gene knockout mouse model; embryonic lethality phenotyping","journal":"Immunobiology","confidence":"High","confidence_rationale":"Tier 2 — clean knockout with defined embryonic lethal phenotype at two developmental stages","pmids":["20961651"],"is_preprint":false},{"year":2014,"finding":"TGFBRAP1 (hVps39-2/TRAP1) was characterized as the likely missing Vps3 subunit of the human CORVET tethering complex. TGFBRAP1 strongly co-localizes with co-expressed Rab5 and interacts directly with Rab5-GTP in vitro, identifying it as an effector of the early endosomal GTPase Rab5 and placing it as an endosomal protein with a role as a CORVET subunit.","method":"Co-localization (confocal microscopy); in vitro binding assay with Rab5-GTP; yeast complementation assays; HEK293 cell studies","journal":"Cellular logistics","confidence":"Medium","confidence_rationale":"Tier 2 — direct in vitro binding to Rab5-GTP and co-localization, but single lab and yeast complementation was negative","pmids":["25750764"],"is_preprint":false},{"year":2014,"finding":"Within the mammalian CORVET/HOPS shared core, VPS11 acts as a molecular switch that binds either CORVET-specific TGFBRAP1 or HOPS-specific VPS39/RILP, allowing selective targeting of the tethering complexes to early or late endosomes respectively to time fusion events in the endo/lysosomal pathway.","method":"Affinity-purification/co-immunoprecipitation analysis of mammalian CORVET and HOPS subunit interactions; functional endosomal targeting assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP defining the molecular switch mechanism, multiple subunit interactions mapped, Moderate evidence from detailed biochemical analysis","pmids":["26463206"],"is_preprint":false},{"year":2014,"finding":"Tgfbrap1 was identified as the CORVET-specific subunit and functional ortholog of yeast Vps3p in mammals. Tgfbrap1 is differentially distributed between APPL1-positive and EEA1-positive early endosome subpopulations. Depletion of CORVET-specific subunits (including Tgfbrap1) caused fragmentation of APPL1-positive endosomes but not EEA1 endosomes, and accumulation of large EEA1 endosomes, indicating roles in both endosome fusion and conversion of EEA1 endosomes into late endosomes.","method":"siRNA depletion; in vivo and in vitro endosome fusion assays; fluorescence microscopy of endosomal markers","journal":"Traffic (Copenhagen, Denmark)","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function with specific endosomal phenotypes (fragmentation of APPL1 endosomes, accumulation of EEA1 endosomes) confirmed in vivo and in vitro","pmids":["25266290"],"is_preprint":false},{"year":2019,"finding":"TGFBRAP1 plays a critical role in chitinase 1 (CHIT1) enhancement of TGF-β1 signaling and fibrotic responses. CHIT1 physically interacts with TGFBRAP1, and TGFBRAP1 is required for CHIT1-mediated enhancement of TGF-β1 downstream effector responses and inhibition of the TGF-β1 feedback inhibitor SMAD7, as demonstrated in pulmonary fibrosis models.","method":"Co-immunoprecipitation (CHIT1–TGFBRAP1 interaction); siRNA knockdown of TGFBRAP1 with TGF-β signaling readouts; fibrotic cellular and tissue assays","journal":"Life science alliance","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP and loss-of-function with defined signaling readout (SMAD7 suppression), single lab","pmids":["31085559"],"is_preprint":false}],"current_model":"TGFBRAP1 is a cytoplasmic protein that functions as a molecular chaperone for Smad4 in TGF-β signaling—binding inactive TGF-β receptor complexes, releasing upon activation, and facilitating Smad4 transfer to receptor-activated Smads—and also serves as the mammalian CORVET tethering complex subunit orthologous to yeast Vps3, where it interacts directly with Rab5-GTP on early endosomes, is selected by VPS11 to direct CORVET (versus HOPS) to early endosomes, and is required for fusion and maturation of distinct early endosome subpopulations."},"narrative":{"teleology":[{"year":1998,"claim":"The initial discovery that TGFBRAP1 physically associates with the activated TGF-β type I receptor established it as a novel component of TGF-β signaling and showed that a dominant-negative fragment could inhibit pathway output.","evidence":"Yeast two-hybrid with constitutively active TβR-I bait; mammalian co-immunoprecipitation; TGF-β reporter assay","pmids":["9545258"],"confidence":"High","gaps":["Mechanism by which TGFBRAP1 modulates receptor signaling was unknown","No downstream effectors (Smads) yet linked to TGFBRAP1","In vivo relevance not tested"]},{"year":2001,"claim":"Demonstrating that TGFBRAP1 functions as a Smad4 chaperone—associating with inactive receptors, releasing upon activation, and escorting Smad4 to receptor-activated Smads—resolved how it promotes signal transduction rather than merely associating with receptors.","evidence":"Co-immunoprecipitation; FRET; deletion mutant analysis; TGF-β reporter assays in mammalian cells","pmids":["11278302"],"confidence":"High","gaps":["Structural basis of the TGFBRAP1–Smad4 interaction unknown","Whether TGFBRAP1 is required for activin versus TGF-β signaling equally was not resolved","No in vivo loss-of-function data"]},{"year":2010,"claim":"The finding that homozygous Tgfbrap1 knockout causes embryonic lethality at pre-blastula and gastrulation stages established a non-redundant in vivo requirement, consistent with its role in TGF-β superfamily signaling during early development.","evidence":"Gene knockout mouse model with embryonic lethality phenotyping","pmids":["20961651"],"confidence":"High","gaps":["Which signaling pathway(s) account for each lethal time point was not determined","Tissue-specific or conditional knockouts not reported","Endosomal trafficking role in embryonic lethality not assessed"]},{"year":2014,"claim":"Identification of TGFBRAP1 as the mammalian CORVET-specific subunit (Vps3 ortholog) that directly binds Rab5-GTP, and the demonstration that VPS11 selects TGFBRAP1 versus VPS39 to target CORVET to early endosomes, revealed an unexpected second function in endosomal tethering and explained how early and late endosome fusion events are separately controlled.","evidence":"In vitro Rab5-GTP binding; confocal co-localization; affinity-purification and co-IP of CORVET/HOPS subunits; siRNA depletion with endosomal marker analysis; in vivo and in vitro endosome fusion assays","pmids":["25750764","26463206","25266290"],"confidence":"High","gaps":["Structural basis of VPS11's selectivity for TGFBRAP1 versus VPS39 unresolved","Whether the TGF-β chaperone and CORVET functions are mutually exclusive or coordinated is unknown","Yeast complementation by mammalian TGFBRAP1 was negative, leaving open whether the Vps3 orthology is complete"]},{"year":2019,"claim":"The finding that chitinase 1 physically interacts with TGFBRAP1 and requires it for enhancement of TGF-β1 signaling and suppression of the feedback inhibitor SMAD7 extended the chaperone function to a pathological fibrotic context.","evidence":"Co-immunoprecipitation of CHIT1–TGFBRAP1; siRNA knockdown with TGF-β signaling readouts in pulmonary fibrosis models","pmids":["31085559"],"confidence":"Medium","gaps":["Mechanism by which CHIT1 engagement of TGFBRAP1 enhances Smad4 delivery is unknown","In vivo confirmation in fibrosis models with genetic TGFBRAP1 ablation not reported","Whether this interaction is relevant beyond pulmonary fibrosis is untested"]},{"year":null,"claim":"A central unresolved question is how the dual roles of TGFBRAP1—as a TGF-β/Smad4 chaperone and a CORVET tethering subunit—are coordinated, whether they are functionally interdependent, and which function accounts for the embryonic lethality of the knockout.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural data for TGFBRAP1 in either complex","Conditional or tissue-specific loss-of-function studies not available","Relative contributions of TGF-β chaperone versus CORVET function to physiology are unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[2]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,2,7]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,2]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,2]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[4,6]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,2,7]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[4,5,6]}],"complexes":["CORVET"],"partners":["TGFBR1","SMAD4","RAB5","VPS11","CHIT1"],"other_free_text":[]},"mechanistic_narrative":"TGFBRAP1 is a bifunctional cytoplasmic protein that operates both as a molecular chaperone in TGF-β/activin signaling and as a subunit of the mammalian CORVET endosomal tethering complex. In the TGF-β pathway, TGFBRAP1 associates with inactive heteromeric TGF-β receptor complexes, is released upon ligand-induced receptor activation, and escorts Smad4 to the activated receptor to facilitate its transfer to receptor-activated Smads such as Smad2 [PMID:9545258, PMID:11278302]. As the mammalian ortholog of yeast Vps3, TGFBRAP1 binds Rab5-GTP directly and is incorporated into the CORVET complex via VPS11, which acts as a molecular switch selecting TGFBRAP1 (CORVET) versus VPS39 (HOPS) to direct tethering to early versus late endosomes; depletion of TGFBRAP1 causes fragmentation of APPL1-positive early endosomes and impaired maturation of EEA1-positive endosomes [PMID:25266290, PMID:26463206]. Homozygous knockout in mice results in embryonic lethality before the blastula stage or during gastrulation, demonstrating a non-redundant developmental requirement [PMID:20961651]."},"prefetch_data":{"uniprot":{"accession":"Q8WUH2","full_name":"Transforming growth factor-beta receptor-associated protein 1","aliases":[],"length_aa":860,"mass_kda":97.2,"function":"Plays a role in the TGF-beta/activin signaling pathway. It associates with inactive heteromeric TGF-beta and activin receptor complexes, mainly through the type II receptor, and is released upon activation of signaling. May recruit SMAD4 to the vicinity of the receptor complex and facilitate its interaction with receptor-regulated Smads, such as SMAD2 Plays a role in vesicle-mediated protein trafficking of the endocytic membrane transport pathway. Believed to act as a component of the putative CORVET endosomal tethering complexes which is proposed to be involved in the Rab5-to-Rab7 endosome conversion probably implicating MON1A/B, and via binding SNAREs and SNARE complexes to mediate tethering and docking events during SNARE-mediated membrane fusion. The CORVET complex is proposed to function as a Rab5 effector to mediate early endosome fusion probably in specific endosome subpopulations (PubMed:25266290). Functions predominantly in APPL1-containing endosomes and in degradative but not recycling trafficking of endocytosed cargo (PubMed:25266290)","subcellular_location":"Cytoplasm; Early endosome","url":"https://www.uniprot.org/uniprotkb/Q8WUH2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TGFBRAP1","classification":"Not Classified","n_dependent_lines":199,"n_total_lines":1208,"dependency_fraction":0.16473509933774835},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000135966","cell_line_id":"CID001788","localizations":[{"compartment":"vesicles","grade":3}],"interactors":[{"gene":"VPS18","stoichiometry":10.0},{"gene":"VPS8","stoichiometry":10.0},{"gene":"VPS11","stoichiometry":4.0},{"gene":"RPL32","stoichiometry":0.2},{"gene":"VPS16","stoichiometry":0.2},{"gene":"VPS33A","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001788","total_profiled":1310},"omim":[{"mim_id":"612188","title":"VPS39 SUBUNIT OF HOPS COMPLEX; VPS39","url":"https://www.omim.org/entry/612188"},{"mim_id":"611919","title":"RIBOSOMAL OXYGENASE 1; RIOX1","url":"https://www.omim.org/entry/611919"},{"mim_id":"606237","title":"TRANSFORMING GROWTH FACTOR-BETA RECEPTOR-ASSOCIATED PROTEIN 1; TGFBRAP1","url":"https://www.omim.org/entry/606237"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TGFBRAP1"},"hgnc":{"alias_symbol":["TRAP-1","TRAP1","VPS3"],"prev_symbol":[]},"alphafold":{"accession":"Q8WUH2","domains":[{"cath_id":"-","chopping":"690-791","consensus_level":"medium","plddt":84.2441,"start":690,"end":791},{"cath_id":"-","chopping":"810-847","consensus_level":"high","plddt":80.8363,"start":810,"end":847}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WUH2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WUH2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WUH2-F1-predicted_aligned_error_v6.png","plddt_mean":87.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TGFBRAP1","jax_strain_url":"https://www.jax.org/strain/search?query=TGFBRAP1"},"sequence":{"accession":"Q8WUH2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8WUH2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8WUH2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WUH2"}},"corpus_meta":[{"pmid":"17579517","id":"PMC_17579517","title":"PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.","date":"2007","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/17579517","citation_count":497,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10652318","id":"PMC_10652318","title":"The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10652318","citation_count":293,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23564345","id":"PMC_23564345","title":"Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23564345","citation_count":224,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17513296","id":"PMC_17513296","title":"Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17513296","citation_count":167,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21878357","id":"PMC_21878357","title":"TRAP-1, the mitochondrial Hsp90.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/21878357","citation_count":146,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17853063","id":"PMC_17853063","title":"Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis.","date":"2007","source":"Stress (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/17853063","citation_count":144,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19217207","id":"PMC_19217207","title":"TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells.","date":"2009","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/19217207","citation_count":122,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20647321","id":"PMC_20647321","title":"Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents.","date":"2010","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20647321","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15292218","id":"PMC_15292218","title":"Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15292218","citation_count":114,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39088352","id":"PMC_39088352","title":"TRAP1 drives smooth muscle cell senescence and promotes atherosclerosis via HDAC3-primed histone H4 lysine 12 lactylation.","date":"2024","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/39088352","citation_count":113,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22319455","id":"PMC_22319455","title":"The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.","date":"2012","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22319455","citation_count":112,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25785725","id":"PMC_25785725","title":"Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1.","date":"2015","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/25785725","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24731398","id":"PMC_24731398","title":"Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells.","date":"2014","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24731398","citation_count":110,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28405578","id":"PMC_28405578","title":"The Chaperone TRAP1 As a Modulator of the Mitochondrial Adaptations in Cancer Cells.","date":"2017","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/28405578","citation_count":109,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19948822","id":"PMC_19948822","title":"Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer.","date":"2009","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19948822","citation_count":103,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2202738","id":"PMC_2202738","title":"Molecular analysis of the yeast VPS3 gene and the role of its product in vacuolar protein sorting and vacuolar segregation during the cell cycle.","date":"1990","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/2202738","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24152966","id":"PMC_24152966","title":"Whole-exome resequencing reveals recessive mutations in TRAP1 in individuals with CAKUT and VACTERL association.","date":"2013","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/24152966","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31956271","id":"PMC_31956271","title":"Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1.","date":"2020","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31956271","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21979464","id":"PMC_21979464","title":"TRAP1 and the proteasome regulatory particle TBP7/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins.","date":"2011","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/21979464","citation_count":85,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28099845","id":"PMC_28099845","title":"Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28099845","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23525905","id":"PMC_23525905","title":"TRAP1 rescues PINK1 loss-of-function phenotypes.","date":"2013","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23525905","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18287101","id":"PMC_18287101","title":"The ATPase cycle of the mitochondrial Hsp90 analog Trap1.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18287101","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29050400","id":"PMC_29050400","title":"Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease.","date":"2017","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29050400","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29621137","id":"PMC_29621137","title":"TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor.","date":"2018","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/29621137","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19942270","id":"PMC_19942270","title":"Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy.","date":"2009","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19942270","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23735188","id":"PMC_23735188","title":"Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1.","date":"2013","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23735188","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27216192","id":"PMC_27216192","title":"S-nitrosylation of the Mitochondrial Chaperone TRAP1 Sensitizes Hepatocellular Carcinoma Cells to Inhibitors of Succinate Dehydrogenase.","date":"2016","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/27216192","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22281005","id":"PMC_22281005","title":"TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors.","date":"2012","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/22281005","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32320652","id":"PMC_32320652","title":"Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32320652","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24113185","id":"PMC_24113185","title":"Translational control in the stress adaptive response of cancer cells: a novel role for the heat shock protein TRAP1.","date":"2013","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/24113185","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31987035","id":"PMC_31987035","title":"The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis.","date":"2020","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/31987035","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25088416","id":"PMC_25088416","title":"Deletion of the mitochondrial chaperone TRAP-1 uncovers global reprogramming of metabolic networks.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25088416","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22432061","id":"PMC_22432061","title":"New insights into TRAP1 pathway.","date":"2012","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/22432061","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27662365","id":"PMC_27662365","title":"TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma.","date":"2016","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/27662365","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26517089","id":"PMC_26517089","title":"Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26517089","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26202366","id":"PMC_26202366","title":"TRAP1 Provides Protection Against Myocardial Ischemia-Reperfusion Injury by Ameliorating Mitochondrial Dysfunction.","date":"2015","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26202366","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24990602","id":"PMC_24990602","title":"TRAP1 revisited: novel localizations and functions of a 'next-generation' biomarker (review).","date":"2014","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24990602","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21338643","id":"PMC_21338643","title":"Mitochondrial TRAP1 regulates the unfolded protein response in the endoplasmic reticulum.","date":"2011","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/21338643","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20471161","id":"PMC_20471161","title":"Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases.","date":"2010","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/20471161","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29476049","id":"PMC_29476049","title":"Vps3 and Vps8 control integrin trafficking from early to recycling endosomes and regulate integrin-dependent functions.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29476049","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27977010","id":"PMC_27977010","title":"TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition.","date":"2016","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/27977010","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25531069","id":"PMC_25531069","title":"A novel N-terminal extension in mitochondrial TRAP1 serves as a thermal regulator of chaperone activity.","date":"2014","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/25531069","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22978347","id":"PMC_22978347","title":"Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium.","date":"2012","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22978347","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23139614","id":"PMC_23139614","title":"Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.","date":"2012","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/23139614","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28678347","id":"PMC_28678347","title":"TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination.","date":"2017","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28678347","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34829705","id":"PMC_34829705","title":"TRAP1 in Oxidative Stress and Neurodegeneration.","date":"2021","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34829705","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35614131","id":"PMC_35614131","title":"The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation.","date":"2022","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/35614131","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23284813","id":"PMC_23284813","title":"TRAP1 controls mitochondrial fusion/fission balance through Drp1 and Mff expression.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23284813","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33025742","id":"PMC_33025742","title":"TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas.","date":"2020","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33025742","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28427560","id":"PMC_28427560","title":"Stress-Adaptive Response in Ovarian Cancer Drug Resistance: Role of TRAP1 in Oxidative Metabolism-Driven Inflammation.","date":"2017","source":"Advances in protein chemistry and structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/28427560","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25265088","id":"PMC_25265088","title":"Mitochondrial chaperone TRAP1 activates the mitochondrial UPR and extends healthspan in Drosophila.","date":"2014","source":"Mechanisms of ageing and development","url":"https://pubmed.ncbi.nlm.nih.gov/25265088","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33575209","id":"PMC_33575209","title":"The Mitochondrial Chaperone TRAP1 as a Candidate Target of Oncotherapy.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33575209","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33465424","id":"PMC_33465424","title":"Central role of TRAP1 in the ameliorative effect of oleanolic acid on the mitochondrial-mediated and endoplasmic reticulum stress-excitated apoptosis induced by ochratoxin A.","date":"2021","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/33465424","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26631731","id":"PMC_26631731","title":"Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) Mutation and TRAP1 Inhibitor Gamitrinib-triphenylphosphonium (G-TPP) Induce a Forkhead Box O (FOXO)-dependent Cell Protective Signal from Mitochondria.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26631731","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20961651","id":"PMC_20961651","title":"The TGF-β signaling modulators TRAP1/TGFBRAP1 and VPS39/Vam6/TLP are essential for early embryonic development.","date":"2010","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/20961651","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28664757","id":"PMC_28664757","title":"TRAP1: a viable therapeutic target for future cancer treatments?","date":"2017","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/28664757","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35740911","id":"PMC_35740911","title":"TRAP1 Chaperones the Metabolic Switch in Cancer.","date":"2022","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/35740911","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26084290","id":"PMC_26084290","title":"Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26084290","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33992469","id":"PMC_33992469","title":"Targeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives.","date":"2021","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33992469","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35883436","id":"PMC_35883436","title":"The Mitochondrial HSP90 Paralog TRAP1: Structural Dynamics, Interactome, Role in Metabolic Regulation, and Inhibitors.","date":"2022","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/35883436","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32664214","id":"PMC_32664214","title":"Inhibition of HDAC1/2 Along with TRAP1 Causes Synthetic Lethality in Glioblastoma Model Systems.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32664214","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31085559","id":"PMC_31085559","title":"Chitinase 1 regulates pulmonary fibrosis by modulating TGF-β/SMAD7 pathway via TGFBRAP1 and FOXO3.","date":"2019","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/31085559","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32438819","id":"PMC_32438819","title":"Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.","date":"2020","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/32438819","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27754870","id":"PMC_27754870","title":"Transgenic Expression of the Mitochondrial Chaperone TNFR-associated Protein 1 (TRAP1) Accelerates Prostate Cancer Development.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27754870","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23418473","id":"PMC_23418473","title":"Effects of TRAP-1-like protein (TLP) gene on collagen synthesis induced by TGF-β/Smad signaling in human dermal fibroblasts.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23418473","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27072803","id":"PMC_27072803","title":"Past, present, and emerging roles of mitochondrial heat shock protein TRAP1 in the metabolism and regulation of cancer stem cells.","date":"2016","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/27072803","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33934112","id":"PMC_33934112","title":"HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33934112","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31097545","id":"PMC_31097545","title":"Myc-mediated transcriptional regulation of the mitochondrial chaperone TRAP1 controls primary and metastatic tumor growth.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31097545","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28088229","id":"PMC_28088229","title":"Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.","date":"2017","source":"Diagnostic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28088229","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24297638","id":"PMC_24297638","title":"TRAP1 role in endoplasmic reticulum stress protection favors resistance to anthracyclins in breast carcinoma cells.","date":"2013","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24297638","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32784002","id":"PMC_32784002","title":"Mitochondrial chaperone, TRAP1 modulates mitochondrial dynamics and promotes tumor metastasis.","date":"2020","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/32784002","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34758612","id":"PMC_34758612","title":"Mitoquinone Inactivates Mitochondrial Chaperone TRAP1 by Blocking the Client Binding Site.","date":"2021","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/34758612","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25493016","id":"PMC_25493016","title":"Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.","date":"2014","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/25493016","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25750764","id":"PMC_25750764","title":"The Vps39-like TRAP1 is an effector of Rab5 and likely the missing Vps3 subunit of human CORVET.","date":"2014","source":"Cellular logistics","url":"https://pubmed.ncbi.nlm.nih.gov/25750764","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20499060","id":"PMC_20499060","title":"Antibody responses to galectin-8, TARP and TRAP1 in prostate cancer patients treated with a GM-CSF-secreting cellular immunotherapy.","date":"2010","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/20499060","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32088262","id":"PMC_32088262","title":"S-nitrosylation affects TRAP1 structure and ATPase activity and modulates cell response to apoptotic stimuli.","date":"2020","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32088262","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27422900","id":"PMC_27422900","title":"TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells.","date":"2016","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27422900","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33369425","id":"PMC_33369425","title":"Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.","date":"2020","source":"The journal of physical chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/33369425","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24286320","id":"PMC_24286320","title":"Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1), leads to mitochondrial aberrations in mouse fibroblast NIH/3T3 cells.","date":"2014","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/24286320","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28710113","id":"PMC_28710113","title":"TRAP1 ameliorates renal tubulointerstitial fibrosis in mice with unilateral ureteral obstruction by protecting renal tubular epithelial cell mitochondria.","date":"2017","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/28710113","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22116673","id":"PMC_22116673","title":"Concomitant inhibition of HSP90, its mitochondrial localized homologue TRAP1 and HSP27 by green tea in pancreatic cancer HPAF-II cells.","date":"2011","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/22116673","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24520224","id":"PMC_24520224","title":"Combination of TRAP1 and ERCC1 Expression Predicts Clinical Outcomes in Metastatic Colorectal Cancer Treated with Oxaliplatin/5-Fluorouracil.","date":"2014","source":"Cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/24520224","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31181660","id":"PMC_31181660","title":"Activation of LXR Receptors and Inhibition of TRAP1 Causes Synthetic Lethality in Solid Tumors.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31181660","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15507488","id":"PMC_15507488","title":"Translocation of the Dictyostelium TRAP1 homologue to mitochondria induces a novel prestarvation response.","date":"2004","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/15507488","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12372338","id":"PMC_12372338","title":"Unique behavior of a dictyostelium homologue of TRAP-1, coupling with differentiation of D. discoideum cells.","date":"2002","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/12372338","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28177905","id":"PMC_28177905","title":"TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28177905","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26071104","id":"PMC_26071104","title":"TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26071104","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15652353","id":"PMC_15652353","title":"Changes in spatial and temporal localization of Dictyostelium homologues of TRAP1 and GRP94 revealed by immunoelectron microscopy.","date":"2005","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/15652353","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25655281","id":"PMC_25655281","title":"Functional characterization of TRAP1-like protein involved in modulating fibrotic processes mediated by TGF-β/Smad signaling in hypertrophic scar fibroblasts.","date":"2015","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/25655281","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36507721","id":"PMC_36507721","title":"Structure, Function, and Inhibitors of the Mitochondrial Chaperone TRAP1.","date":"2022","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36507721","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23840658","id":"PMC_23840658","title":"The N-terminal domains of Vps3 and Vps8 are critical for localization and function of the CORVET tethering complex on endosomes.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23840658","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37983591","id":"PMC_37983591","title":"Targeting the Mitochondrial Chaperone TRAP1 Alleviates Vascular Pathologies in Ischemic Retinopathy.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37983591","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26716385","id":"PMC_26716385","title":"Downregulation of TRAP1 sensitizes glioblastoma cells to temozolomide chemotherapy through regulating metabolic reprogramming.","date":"2016","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/26716385","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34906113","id":"PMC_34906113","title":"TRAP1 suppresses oral squamous cell carcinoma progression by reducing oxidative phosphorylation metabolism of Cancer-associated fibroblasts.","date":"2021","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34906113","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28407697","id":"PMC_28407697","title":"Cytosolic Hsp90α and its mitochondrial isoform Trap1 are differentially required in a breast cancer model.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28407697","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36510251","id":"PMC_36510251","title":"Regulation of mitochondrial complex III activity and assembly by TRAP1 in cancer cells.","date":"2022","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/36510251","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29991590","id":"PMC_29991590","title":"Calcium binding to a remote site can replace magnesium as cofactor for mitochondrial Hsp90 (TRAP1) ATPase activity.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29991590","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37679468","id":"PMC_37679468","title":"TRAP1 inhibits MARCH5-mediated MIC60 degradation to alleviate mitochondrial dysfunction and apoptosis of cardiomyocytes under diabetic conditions.","date":"2023","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/37679468","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24382805","id":"PMC_24382805","title":"Guardian of the furnace: mitochondria, TRAP1, ROS and stem cell maintenance.","date":"2013","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/24382805","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29807796","id":"PMC_29807796","title":"New TRAP1 and Hsp90 chaperone inhibitors with cationic components: Preliminary studies on mitochondrial targeting.","date":"2018","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/29807796","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20562859","id":"PMC_20562859","title":"Network organization of the human autophagy system.","date":"2010","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/20562859","citation_count":1286,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28388416","id":"PMC_28388416","title":"An Approach to Spatiotemporally Resolve Protein Interaction Networks in Living Cells.","date":"2017","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/28388416","citation_count":328,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23251661","id":"PMC_23251661","title":"Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23251661","citation_count":312,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28611215","id":"PMC_28611215","title":"Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28611215","citation_count":282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29117863","id":"PMC_29117863","title":"RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination.","date":"2017","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/29117863","citation_count":135,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20379614","id":"PMC_20379614","title":"Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.","date":"2010","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/20379614","citation_count":108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10051563","id":"PMC_10051563","title":"Interaction of 5-lipoxygenase with cellular proteins.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10051563","citation_count":105,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31092635","id":"PMC_31092635","title":"CORVET, CHEVI and HOPS - multisubunit tethers of the endo-lysosomal system in health and disease.","date":"2019","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/31092635","citation_count":96,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26463206","id":"PMC_26463206","title":"Characterization of the Mammalian CORVET and HOPS Complexes and Their Modular Restructuring for Endosome Specificity.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26463206","citation_count":85,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19754311","id":"PMC_19754311","title":"Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03).","date":"2009","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19754311","citation_count":83,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25266290","id":"PMC_25266290","title":"Mammalian CORVET is required for fusion and conversion of distinct early endosome subpopulations.","date":"2014","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/25266290","citation_count":81,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11278302","id":"PMC_11278302","title":"Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278302","citation_count":73,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21998450","id":"PMC_21998450","title":"Conditional deletion of TGF-βR1 using Langerin-Cre mice results in Langerhans cell deficiency and reduced contact hypersensitivity.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21998450","citation_count":66,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35831314","id":"PMC_35831314","title":"Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35831314","citation_count":65,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"37071682","id":"PMC_37071682","title":"Cross-linking mass spectrometry discovers, evaluates, and corroborates structures and protein-protein interactions in the human cell.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37071682","citation_count":60,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9545258","id":"PMC_9545258","title":"A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor beta receptor.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9545258","citation_count":59,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27301951","id":"PMC_27301951","title":"Variations of chromosome 2 gene expressions among patients with lung cancer or non-cancer.","date":"2016","source":"Cell biology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/27301951","citation_count":53,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23551011","id":"PMC_23551011","title":"Genome-wide association study of pre-eclampsia detects novel maternal single nucleotide polymorphisms and copy-number variants in subsets of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study cohort.","date":"2013","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23551011","citation_count":51,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30836988","id":"PMC_30836988","title":"Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma.","date":"2019","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/30836988","citation_count":49,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48379,"output_tokens":8338,"usd":0.135103},"stage2":{"model":"claude-opus-4-6","input_tokens":12222,"output_tokens":4152,"usd":0.247365},"total_usd":0.625815,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":62311,"output_tokens":3687,"usd":0.121119},"round2_rules_fired":"R2,R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":5947,"output_tokens":2070,"usd":0.122228}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"TRAP1 is localized to mitochondria via a mitochondrial localization sequence at its N-terminus, binds ATP, and exhibits ATPase activity inhibitable by geldanamycin and radicicol, but unlike Hsp90, does not form stable complexes with co-chaperones p23 and Hop and cannot substitute for Hsp90 in progesterone receptor reconstitution.\",\n      \"method\": \"Immunofluorescence, in vitro ATPase assay, co-chaperone binding assay, hormone-binding reconstitution assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple in vitro assays with direct functional readouts; foundational characterization paper\",\n      \"pmids\": [\"10652318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PINK1 phosphorylates TRAP1 both in vitro and in vivo; PINK1 binds and colocalizes with TRAP1 in mitochondria; PINK1 protects against oxidative-stress-induced cytochrome c release and cell death in a manner dependent on its kinase activity to phosphorylate TRAP1; PD-linked PINK1 mutations (G309D, L347P, W437X) impair this phosphorylation and cytoprotection.\",\n      \"method\": \"In vitro kinase assay, co-immunoprecipitation, immunofluorescence colocalization, cell death assays with PINK1 mutants\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay plus mutagenesis, replicated across multiple PD-linked mutations\",\n      \"pmids\": [\"17579517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Granzyme M cleaves TRAP1 and abolishes its antioxidant function, resulting in ROS accumulation and cytochrome c release; TRAP1 silencing increases ROS and sensitizes to GzmM-mediated apoptosis, while TRAP1 overexpression attenuates ROS production.\",\n      \"method\": \"siRNA knockdown, overexpression, ROS measurement, cytochrome c release assay, GzmM cleavage assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct cleavage demonstrated with functional consequence, single lab\",\n      \"pmids\": [\"17513296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TRAP1 ATPase cycle involves ATP binding shifting the protein predominantly to the closed conformation, with reopening being ~10× faster than hydrolysis (rate-limiting step at k_hyd = 0.0039 s⁻¹); the cycle involves a two-step ATP binding mechanism followed by irreversible hydrolysis and one-step ADP release.\",\n      \"method\": \"Biochemical, thermodynamic, and rapid kinetic methods; global fitting of ATPase cycle model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — rigorous kinetic dissection of ATPase mechanism with multiple quantitative methods\",\n      \"pmids\": [\"18287101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TRAP1 interacts with the Ca²⁺-binding protein Sorcin in mitochondria; a specific isoform of Sorcin (<20 kDa) localizes to mitochondria via interaction with TRAP1; TRAP1 depletion reduces mitochondrial Sorcin levels and Sorcin depletion increases TRAP1 degradation, indicating reciprocal stabilization; their interaction is required for Sorcin mitochondrial localization and TRAP1 stability.\",\n      \"method\": \"Proteomic co-immunoprecipitation/mass spectrometry, fluorescence microscopy, Western blot of mitochondrial fractions, shRNA/siRNA knockdown\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, multiple orthogonal methods, reciprocal regulation demonstrated\",\n      \"pmids\": [\"20647321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TRAP1 interacts with TBP7 (an AAA-ATPase of the 19S proteasome regulatory subunit) in the endoplasmic reticulum as shown by FRET and co-localization; TRAP1 silencing under ER stress upregulates BiP/Grp78 and increases intracellular protein ubiquitination; TRAP1/TBP7 interaction controls ubiquitination and stability of specific mitochondria-destined proteins.\",\n      \"method\": \"Mass spectrometry, co-IP, FRET, confocal/electron microscopy, shRNA knockdown, ubiquitination assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including FRET for direct interaction, EM localization, functional ubiquitination data\",\n      \"pmids\": [\"21979464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TRAP1 knockdown activates ER-resident caspase-4 and is associated with the unfolded protein response; TRAP1 knockdown increases basal BiP/Grp78 and decreases CHOP expression, modulating ER stress signaling from mitochondria.\",\n      \"method\": \"siRNA knockdown, caspase-4 activation assay, Western blot for UPR markers\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, functional knockdown with defined markers but limited mechanistic depth\",\n      \"pmids\": [\"21338643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In Drosophila, overexpression of human TRAP1 rescues PINK1 loss-of-function phenotypes (dopamine neuron loss, locomotor defects, oxidative stress sensitivity) but not Parkin loss-of-function, positioning TRAP1 downstream of PINK1 and parallel to or upstream of Parkin; TRAP1 also rescues Complex I activity reduced by α-Synuclein and prevents α-Synuclein-induced mitochondrial fragmentation.\",\n      \"method\": \"Genetic epistasis in Drosophila, siRNA in human cell lines, Complex I activity assay, mitochondrial morphology imaging\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo combined with in vitro functional assays, consistent across multiple model systems\",\n      \"pmids\": [\"23525905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TRAP1 regulates a metabolic switch between oxidative phosphorylation and aerobic glycolysis; TRAP1 deficiency promotes increased mitochondrial respiration, fatty acid oxidation, TCA cycle intermediate accumulation, ATP and ROS increases; TRAP1 interaction with and regulation of mitochondrial c-Src provides a mechanistic basis; TRAP1-deficient cells show enhanced invasiveness.\",\n      \"method\": \"TRAP1-null cells, transient silencing/overexpression, metabolic flux analysis, co-immunoprecipitation with c-Src\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal metabolic approaches, genetic KO, and identified interactor c-Src\",\n      \"pmids\": [\"23564345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TRAP1 is associated with ribosomes and translation factors in colon carcinoma cells; TRAP1 regulates global protein synthesis rate through the eIF2α pathway, favoring GCN2 and PERK kinase activation, phosphorylation of eIF2α, attenuation of cap-dependent translation, and enhanced synthesis of stress-protective proteins (ATF4, BiP/Grp78, xCT).\",\n      \"method\": \"Co-immunoprecipitation with ribosomes and translation factors, phosphorylation assays, polysome profiling, siRNA knockdown\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — ribosome association by co-IP, functional pathway activation shown, but single lab\",\n      \"pmids\": [\"24113185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Crystal structures of human TRAP1 complexed with Hsp90 inhibitors were determined; the middle domain of TRAP1 contains a previously unrecognized drug-binding site (client binding region) distinct from the ATP-binding site; a TRAP1-AMP-PNP complex structure revealed the molecular mechanism of ATP hydrolysis crucial for chaperone function.\",\n      \"method\": \"X-ray crystallography, structure-guided inhibitor design\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures with functional drug design validation\",\n      \"pmids\": [\"25785725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A novel N-terminal 'strap' extension in TRAP1 (absent in yeast and bacteria) stabilizes the closed ATP-bound conformation through trans-protomer interactions and is responsible for unusual temperature dependence of ATPase rates by creating a thermally sensitive kinetic barrier between open and closed conformations; strap release is coupled to N-terminal domain rotation and nucleotide binding pocket lid dynamics.\",\n      \"method\": \"Crystal structure, mutagenesis, ATPase kinetics, biochemical characterization\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with mutagenesis and kinetic analysis\",\n      \"pmids\": [\"25531069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TRAP1 knockout mice show reduced incidence of age-associated pathologies with global upregulation of oxidative phosphorylation and glycolysis transcriptomes, deregulated mitochondrial respiration, oxidative stress, and impaired cell proliferation, establishing TRAP1 as a central regulator of mitochondrial bioenergetics in vivo.\",\n      \"method\": \"TRAP1 knockout mouse model, transcriptome analysis, metabolic measurements\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO with defined metabolic phenotype\",\n      \"pmids\": [\"25088416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TRAP1 interacts with CDK1 and prevents CDK1 ubiquitination in cooperation with the proteasome regulatory particle TBP7; TRAP1 silencing results in enhanced CDK1 ubiquitination, lack of CDK1/cyclin B1 nuclear translocation, and increased MAD2 degradation, blocking G2-M transition; TRAP1 also transcriptionally regulates CDK1, CYCLIN B1, and MAD2.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, gene expression profiling, siRNA knockdown, cell cycle analysis\",\n      \"journal\": \"The Journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP of TRAP1-CDK1 complex, ubiquitination assay, epistasis rescue, multiple cell lines\",\n      \"pmids\": [\"28678347\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"S-nitrosylation of TRAP1 at Cys501 (in GSNOR-deficient hepatocellular carcinoma cells) mediates TRAP1 degradation via the proteasome, leading to increased succinate dehydrogenase levels and activity.\",\n      \"method\": \"S-nitrosylation site identification, proteasome inhibitor rescue, functional SDH activity assay in GSNOR-deficient cells\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — specific PTM site identified with functional consequence, single lab\",\n      \"pmids\": [\"27216192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TRAP1 maintains cancer stem cell phenotype via regulation of Wnt/β-catenin signaling: TRAP1 knockdown reduces stem cell markers, colony formation, and anchorage-independent growth, and downregulates Wnt/β-catenin target genes; mechanistically TRAP1 modulates β-catenin ubiquitination/phosphorylation and frizzled receptor ligand expression.\",\n      \"method\": \"siRNA knockdown, gene expression profiling, colony formation assay, β-catenin ubiquitination assay, IHC in human CRCs\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — defined mechanism with ubiquitination assay and gene expression data, single lab\",\n      \"pmids\": [\"27662365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In neurofibromin-deficient cells, a fraction of active ERK1/2 associates with TRAP1 and succinate dehydrogenase (SDH) in the mitochondrial matrix; TRAP1 inhibits SDH activity and promotes succinate accumulation; ERK1/2 phosphorylates TRAP1 and enhances formation of the TRAP1-ERK1/2-SDH complex; TRAP1 mutagenesis at ERK1/2-targeted serine residues abrogates tumorigenicity.\",\n      \"method\": \"Co-immunoprecipitation, in vitro phosphorylation/mutagenesis, SDH activity assay, metabolomics, tumorigenicity assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct phosphorylation demonstrated, mutagenesis of target sites, functional SDH assay, rescue with succinate analog\",\n      \"pmids\": [\"28099845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TRAP1 acts downstream of HTRA2 and PINK1 for mitochondrial fine tuning; HTRA2 regulates TRAP1 protein levels but TRAP1 is not a direct proteolytic target of HTRA2; TRAP1 overexpression rescues HTRA2- and PINK1-associated mitochondrial dysfunction; a loss-of-function TRAP1 mutation in a Parkinson's disease patient causes increased oxygen consumption, ATP output, ROS, mitochondrial biogenesis, and loss of mitochondrial membrane potential.\",\n      \"method\": \"Mass spectrometry interactome, cell-based rescue experiments, patient-derived fibroblast analysis, oxygen consumption measurements\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — interactome MS plus functional rescue plus patient-derived cells, single lab\",\n      \"pmids\": [\"29050400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Calcium can replace magnesium as cofactor for TRAP1 ATPase activity; anomalous X-ray diffraction revealed a distinct calcium-binding site within the TRAP1 nucleotide-binding pocket near the ATP α-phosphate; calcium-supported hydrolysis is cooperative between the two protomers of the TRAP1 dimer (unlike magnesium-supported non-cooperative hydrolysis), providing a mechanism for mitochondrial calcium signaling to modulate TRAP1 function.\",\n      \"method\": \"Anomalous X-ray diffraction, ATPase kinetics, divalent cation substitution assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with identified binding site combined with kinetic analysis\",\n      \"pmids\": [\"29991590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TRAP1 forms a stable tetramer whose levels change in response to alterations in OXPHOS; the major quantitative interactors are mtHSP70 and HSP60; TRAP1 ATPase activity is dispensable for restoring wild-type OXPHOS levels but modulates interactions with various mitochondrial proteins; disruption of TRAP1 gene dysregulates OXPHOS by inducing anaplerotic glutamine utilization.\",\n      \"method\": \"TRAP1 gene disruption in multiple cell lines, quantitative interactome, ATPase-dead mutant rescue, metabolic flux analysis, native gel electrophoresis for tetramer\",\n      \"journal\": \"BMC biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — comprehensive interactome with multiple cell lines, ATPase mutant functional analysis, novel tetramer identification\",\n      \"pmids\": [\"31987035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"S-nitrosylation of TRAP1 at Cys501 decreases its ATPase activity; molecular dynamics simulations show Cys501 S-nitrosylation induces conformational changes to distal sites; C501S mutant TRAP1 shows enhanced ATPase activity and confers greater protection against staurosporine-induced cell death.\",\n      \"method\": \"In vitro ATPase assay, site-directed mutagenesis (C501S), molecular dynamics simulation, cell death assay\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay with mutagenesis plus computational validation\",\n      \"pmids\": [\"32088262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TRAP1 interacts with phosphofructokinase-1 (PFK1), favoring its glycolytic activity and preventing its ubiquitination/degradation; this interaction is lost under enhanced OXPHOS conditions; TRAP1 regulation of PFK1 drives lactate production to balance low OXPHOS.\",\n      \"method\": \"Co-immunoprecipitation of TRAP1-PFK1 complex, ubiquitination assay, metabolic flux measurements, siRNA knockdown\",\n      \"journal\": \"Molecular oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct interaction shown by co-IP with ubiquitination assay, functional metabolic readout, single lab\",\n      \"pmids\": [\"33025742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"An allosteric pocket distal to the TRAP1 active site was identified computationally and validated experimentally; small molecules targeting this pocket inhibit TRAP1 but not HSP90 ATPase activity and revert TRAP1-dependent downregulation of succinate dehydrogenase activity in cancer cells and in zebrafish larvae.\",\n      \"method\": \"Computational dynamics-based allosteric site identification, in vitro ATPase inhibition assay, SDH activity assay, zebrafish larvae model\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — computationally identified allosteric site validated by in vitro biochemical assays and in vivo model\",\n      \"pmids\": [\"32320652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Mitoquinone (MitoQ) inhibits TRAP1 by binding to previously unrecognized drug-binding sites in the middle domain of TRAP1 (client binding region), competing with TRAP1 clients; structural analyses revealed asymmetric bipartite interaction; MitoQ treatment facilitated identification of 103 TRAP1-interacting mitochondrial proteins in cancer cells.\",\n      \"method\": \"Structural analysis, competitive binding assays, mass spectrometry interactome, in vitro and in vivo anticancer activity assays\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural characterization of binding site with competitive binding validation and interactome mapping\",\n      \"pmids\": [\"34758612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TRAP1 interacts with the OSCP subunit of F-ATP synthase, competing with cyclophilin D (CyPD) for binding; TRAP1 increases F-ATP synthase catalytic activity, counteracts CyPD inhibitory effect, and directly inhibits the permeability transition pore (PTP) channel activity of purified F-ATP synthase; TRAP1 reverses PTP induction by CyPD and antagonizes PTP-dependent mitochondrial depolarization and cell death.\",\n      \"method\": \"Co-immunoprecipitation, competitive binding assay, electrophysiological measurements of purified F-ATP synthase channel, cell death assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro electrophysiology of purified complex, competitive binding, multiple functional readouts\",\n      \"pmids\": [\"35614131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TRAP1 binds the complex III core component UQCRC2 and regulates complex III activity; direct TRAP1-UQCRC2 binding is disrupted when glucose is limiting but TRAP1-complex III binding is maintained, allowing sustained OXPHOS under metabolic stress.\",\n      \"method\": \"Co-immunoprecipitation, complex III activity assay, glucose deprivation metabolic experiments\",\n      \"journal\": \"Cancer cell international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct interaction shown and functional consequence demonstrated, single lab\",\n      \"pmids\": [\"36510251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TRAP1 inhibits MARCH5-mediated K48-linked ubiquitination of MIC60 at Lys285 by competitively binding to MIC60, thereby protecting MIC60 from degradation, preserving mitochondrial cristae structure, and preventing cardiomyocyte apoptosis under diabetic (high glucose/palmitate) conditions.\",\n      \"method\": \"Co-immunoprecipitation (TRAP1-MIC60-MARCH5 competitive binding), ubiquitination site mutagenesis (K285R), MIC60-interacting motif mutagenesis, siRNA knockdown, mitochondrial function assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — competitive binding demonstrated with multiple mutants, specific ubiquitination site identified, functional rescue\",\n      \"pmids\": [\"37679468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TRAP1 promotes aerobic glycolysis in VSMCs, elevating lactate production; accumulated lactate downregulates HDAC3, promoting histone H4 lysine 12 lactylation (H4K12la) at SASP gene promoters; H4K12la activates SASP transcription, driving VSMC senescence and atherosclerosis; VSMC-specific TRAP1 knockout reduces H4K12la, SASP, and plaque area.\",\n      \"method\": \"VSMC-specific Trap1 KO in ApoeKO mice, ChIP analysis, lactylation measurement, metabolic assays, PROTAC-mediated TRAP1 degradation\",\n      \"journal\": \"European heart journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo VSMC-specific KO with ChIP demonstrating epigenetic mechanism, multiple orthogonal approaches\",\n      \"pmids\": [\"39088352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TRAP1 (also called TGFBRAP1) and its homologue VPS39/TLP are both required for early embryonic development in mice; TRAP1-null embryos die before the blastula stage or during gastrulation, demonstrating an essential non-redundant in vivo role.\",\n      \"method\": \"Knockout mouse generation, embryonic lethality phenotyping\",\n      \"journal\": \"Immunobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined developmental phenotype\",\n      \"pmids\": [\"20961651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TRAP1 (hVps39-2) is an effector of Rab5 in the endosomal pathway; it co-localizes with co-expressed Rab5 in mammalian cells and interacts directly with Rab5-GTP in vitro, suggesting a role as a subunit of the putative human CORVET complex.\",\n      \"method\": \"In vitro Rab5-GTP binding assay, co-localization in yeast and HEK293 cells\",\n      \"journal\": \"Cellular logistics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct in vitro binding shown but functional integration into CORVET not fully established\",\n      \"pmids\": [\"25750764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CHIT1 interacts with TGFBRAP1 (TRAP1/TGFBRAP1 in its TGF-β signaling role), and TGFBRAP1 plays a critical role in CHIT1 enhancement of TGF-β1 signaling and fibrotic effector responses, including SMAD7 suppression.\",\n      \"method\": \"Co-immunoprecipitation of CHIT1-TGFBRAP1 interaction, TGF-β signaling assays, siRNA knockdown\",\n      \"journal\": \"Life science alliance\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct protein interaction shown with functional pathway consequence, single lab\",\n      \"pmids\": [\"31085559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"BRAF interacts with TRAP1; activated BRAF signaling results in enhanced TRAP1 serine-phosphorylation associated with resistance to apoptosis; a BRAF dominant-negative mutant prevents TRAP1 serine phosphorylation; TRAP1 acts as a downstream effector of BRAF cytoprotective pathway in mitochondria.\",\n      \"method\": \"Co-immunoprecipitation of BRAF-TRAP1, serine phosphorylation assay, dominant-negative BRAF mutant, apoptosis assays\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct interaction and phosphorylation demonstrated, functional consequence shown, single lab\",\n      \"pmids\": [\"26084290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TRAP1 knockdown causes abnormal mitochondrial morphology with significant decreases in fission proteins Drp1 and Mff, which are rescued by proteasome inhibitor MG132, without affecting fusion protein levels; TRAP1 controls mitochondrial fusion/fission balance through regulation of fission protein stability.\",\n      \"method\": \"Stable and transient TRAP1 knockdown, mitochondrial morphology imaging, proteasome inhibitor rescue, Western blot for fission/fusion proteins\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined molecular mechanism (proteasome-dependent Drp1/Mff degradation), replicated in two cell lines\",\n      \"pmids\": [\"23284813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In Drosophila, TRAP1 mutation or knockdown enhances survival under oxidative stress and activates FOXO-dependent transcription (Thor); deletion of FOXO nullifies the protective effects of TRAP1 mutation against oxidative stress and PINK1 mutation, establishing FOXO as the downstream effector of TRAP1 loss-induced retrograde cell protective signaling.\",\n      \"method\": \"Drosophila genetic mutants, genetic epistasis with FOXO deletion, oxidative stress assays, DA neuron quantification\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo with defined downstream effector\",\n      \"pmids\": [\"26631731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HIF1α transcriptionally induces TRAP1 expression through conserved hypoxic responsive elements in the TRAP1 promoter; TRAP1 inhibition maintains high respiration under hypoxia, identifying TRAP1 as a primary regulator of mitochondrial bioenergetics downstream of hypoxia/HIF1α.\",\n      \"method\": \"HIF1α stabilization experiments, promoter analysis, TRAP1 KO/inhibitor studies in zebrafish and mammalian cells, oxygen consumption measurements\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter functional analysis combined with genetic KO and pharmacological inhibition, multiple models\",\n      \"pmids\": [\"33934112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Genetic TRAP1 ablation or pharmacological TRAP1 inhibition (MitoQ, SB-U015) in ischemic retinopathy mouse models alleviates BRB breakdown and pathological neovascularization via proteolytic HIF1α degradation mediated by mitochondrial permeability transition pore opening and activation of calcium-dependent protease calpain-1.\",\n      \"method\": \"Trap1 knockout mice, TRAP1 inhibitor treatment, retinal vascular phenotyping, HIF1α degradation assay, calpain-1 activation assay, mPTP opening measurement\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO and pharmacological inhibition with defined molecular mechanism\",\n      \"pmids\": [\"37983591\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TRAP1 is a mitochondrial Hsp90-family chaperone whose ATP-dependent conformational cycle (regulated by a unique N-terminal 'strap', calcium/magnesium cofactor switching, and post-translational modifications including PINK1-mediated phosphorylation, ERK1/2-mediated phosphorylation, and S-nitrosylation at Cys501) enables it to maintain mitochondrial proteostasis and bioenergetics by interacting with and stabilizing client proteins including CDK1, PFK1, UQCRC2 (complex III), F-ATP synthase OSCP subunit, MIC60, c-Src, SDH, and Sorcin, while also functioning in the endoplasmic reticulum with TBP7 to control ubiquitination of mitochondria-destined proteins; collectively these interactions allow TRAP1 to regulate the balance between oxidative phosphorylation and glycolysis, inhibit the mitochondrial permeability transition pore, prevent cytochrome c release, modulate cell cycle G2-M transition, and respond to upstream signals from PINK1, HTRA2, BRAF, ERK, HIF1α, and Myc.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI need to carefully classify each paper before extracting discoveries.\n\n**Key insight:** There are TWO different proteins called \"TRAP1\" in this corpus:\n1. **TGFBRAP1** (TGF-β Receptor Associated Protein 1, also called TRAP-1 in TGF-β signaling context) — a cytoplasmic protein involved in TGF-β/Smad signaling, and also identified as the mammalian CORVET subunit (Vps3 homolog)\n2. **TRAP1/HSP75** (TNF Receptor-Associated Protein 1, mitochondrial Hsp90) — a completely different protein, a mitochondrial chaperone\n\nThe gene being queried is **TGFBRAP1** (HGNC: TGF-beta receptor-associated protein 1). Looking at the NCBI gene page, TGFBRAP1 is the gene encoding the protein that:\n- Was identified as binding to TGF-β receptor type I\n- Is also known as TRAP-1 in TGF-β signaling\n- Functions as a subunit of the CORVET complex (Vps3 homolog)\n\nThe mitochondrial chaperone papers (TRAP1/HSP75/Hsp90 family) are about a **completely different gene** — the mitochondrial Hsp90 (gene name: TRAP1, also called HSPC75). This is an **ALIAS COLLISION** — both proteins have been called \"TRAP1\" but they are distinct gene products.\n\nLet me verify: TGFBRAP1 (Gene ID: 9392) vs TRAP1/mitochondrial HSP90 (Gene ID: 10131). These are indeed different genes.\n\nPapers about TGFBRAP1 (the TGF-β signaling/CORVET protein):\n- PMID:11278302 — TRAP1 as Smad4 chaperone in TGF-β signaling ✓ KEEP\n- PMID:9545258 — Novel protein binding activated TbetaR-I ✓ KEEP  \n- PMID:20961651 — TRAP1/TGFBRAP1 and VPS39 in embryonic development ✓ KEEP\n- PMID:25750764 — hVps39-2/TRAP1 as Rab5 effector, CORVET subunit ✓ KEEP\n- PMID:26463206 — VPS11 binds TGFBRAP1 in CORVET ✓ KEEP\n- PMID:25266290 — Tgfbrap1 as CORVET-specific subunit ✓ KEEP\n- PMID:10051563 — 5-LO interaction with TGF-β receptor-I-associated protein ✓ KEEP\n- PMID:31085559 — CHIT1 regulates TGF-β/SMAD7 via TGFBRAP1 ✓ KEEP\n- PMID:23418473 — TLP (TRAP1-like protein/VPS39) effects on TGF-β/Smad — this describes TLP/VPS39, which is a homologue, not TGFBRAP1 itself. EXCLUDE (paralog)\n- PMID:25655281 — TLP functional characterization — same issue, TLP is VPS39 homolog. EXCLUDE (paralog)\n- PMID:20961651 — mentions both TRAP1 and VPS39/TLP as separate entities ✓ KEEP (covers TGFBRAP1)\n\nAll the mitochondrial chaperone papers (PMID:17579517, 10652318, 23564345, etc.) are ALIAS COLLISION — EXCLUDE.\n\nPapers from gene2pubmed:\n- PMID:19754311 — GWAS finding TGFBRAP1 SNP associated with AIDS progression — expression/association only, no mechanism. EXCLUDE (no mechanistic finding)\n- PMID:20562859 (autophagy network) — large interactome, TGFBRAP1 may appear. No specific mechanism for TGFBRAP1. EXCLUDE\n- PMID:26186194, 28514442, 33961781 (BioPlex) — large interactome datasets. No specific mechanism. EXCLUDE\n- PMID:26496610 (Hein et al) — large interactome. EXCLUDE\n- PMID:35271311 (OpenCell) — localization data. Could be relevant if it shows TGFBRAP1 localization. EXCLUDE (no specific mechanistic finding extracted)\n- PMID:29476049 — Vps3 and Vps8 control integrin trafficking — about yeast/mammalian CORVET Vps3 (not TGFBRAP1 specifically). EXCLUDE (yeast Vps3, not TGFBRAP1)\n- PMID:23840658 — Vps3/Vps8 N-terminal domains in CORVET — yeast. EXCLUDE (yeast)\n- PMID:2202738 — Yeast VPS3 gene — yeast. EXCLUDE (yeast, not mammalian TGFBRAP1)\n- PMID:29991590 — calcium/TRAP1 ATPase — mitochondrial chaperone. EXCLUDE\n- PMID:37679468 — TRAP1 inhibits MARCH5 — mitochondrial chaperone. EXCLUDE\n\nNow extracting from KEPT papers:\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"TGFBRAP1 (TRAP-1) was identified as a novel protein that selectively interacts with the activated (but not quiescent) form of type I TGF-β receptor (TbetaR-I). In yeast two-hybrid and mammalian co-precipitation assays, TRAP-1 bound constitutively active (L193A/P194A/T204D) and ligand-activated TbetaR-I but not wild-type TbetaR-I in the absence of TGF-β. A partial TRAP-1 construct inhibited TGF-β signaling as measured by a TGF-β-dependent reporter gene.\",\n      \"method\": \"Yeast two-hybrid screen with activated TbetaR-I bait; co-immunoprecipitation in mammalian cells; TGF-β reporter gene assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP in yeast and mammalian cells, functional reporter assay, Moderate evidence from single lab with multiple orthogonal methods\",\n      \"pmids\": [\"9545258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"TGFBRAP1 (TGF-β receptor-I-associated protein 1) was identified as an interactor of 5-lipoxygenase (5-LO) in a yeast two-hybrid screen of a human lung cDNA library, suggesting a potential link between TGF-β receptor signaling and leukotriene synthesis pathways.\",\n      \"method\": \"Yeast two-hybrid screen\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single yeast two-hybrid result, no follow-up validation of the 5-LO/TGFBRAP1 interaction\",\n      \"pmids\": [\"10051563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TGFBRAP1 (TRAP1) was shown to function as a molecular chaperone for Smad4 in TGF-β signaling. TRAP1 associates with inactive heteromeric TGF-β and activin receptor complexes and is released upon receptor activation. In a ligand-dependent fashion, TRAP1 interacts with Smad4 (the common mediator Smad). Deletion constructs of TRAP1 inhibit TGF-β signaling and diminish the Smad4–Smad2 interaction, consistent with a model in which TRAP1 escorts Smad4 to the activated receptor complex to facilitate its transfer to receptor-activated Smads.\",\n      \"method\": \"Co-immunoprecipitation; deletion mutant functional analysis; TGF-β signaling reporter assays; fluorescence resonance energy transfer (FRET)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (Co-IP, dominant-negative deletion mutants, reporter assays, FRET), Moderate evidence from single lab\",\n      \"pmids\": [\"11278302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TGFBRAP1 (TRAP1) is essential for early embryonic development. Mice with homozygous deletion of TRAP1 die at two defined timepoints: before the blastula stage or during gastrulation, demonstrating a non-redundant requirement for TRAP1 in embryogenesis. Heterozygous mice are phenotypically normal.\",\n      \"method\": \"Gene knockout mouse model; embryonic lethality phenotyping\",\n      \"journal\": \"Immunobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout with defined embryonic lethal phenotype at two developmental stages\",\n      \"pmids\": [\"20961651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TGFBRAP1 (hVps39-2/TRAP1) was characterized as the likely missing Vps3 subunit of the human CORVET tethering complex. TGFBRAP1 strongly co-localizes with co-expressed Rab5 and interacts directly with Rab5-GTP in vitro, identifying it as an effector of the early endosomal GTPase Rab5 and placing it as an endosomal protein with a role as a CORVET subunit.\",\n      \"method\": \"Co-localization (confocal microscopy); in vitro binding assay with Rab5-GTP; yeast complementation assays; HEK293 cell studies\",\n      \"journal\": \"Cellular logistics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct in vitro binding to Rab5-GTP and co-localization, but single lab and yeast complementation was negative\",\n      \"pmids\": [\"25750764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Within the mammalian CORVET/HOPS shared core, VPS11 acts as a molecular switch that binds either CORVET-specific TGFBRAP1 or HOPS-specific VPS39/RILP, allowing selective targeting of the tethering complexes to early or late endosomes respectively to time fusion events in the endo/lysosomal pathway.\",\n      \"method\": \"Affinity-purification/co-immunoprecipitation analysis of mammalian CORVET and HOPS subunit interactions; functional endosomal targeting assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP defining the molecular switch mechanism, multiple subunit interactions mapped, Moderate evidence from detailed biochemical analysis\",\n      \"pmids\": [\"26463206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Tgfbrap1 was identified as the CORVET-specific subunit and functional ortholog of yeast Vps3p in mammals. Tgfbrap1 is differentially distributed between APPL1-positive and EEA1-positive early endosome subpopulations. Depletion of CORVET-specific subunits (including Tgfbrap1) caused fragmentation of APPL1-positive endosomes but not EEA1 endosomes, and accumulation of large EEA1 endosomes, indicating roles in both endosome fusion and conversion of EEA1 endosomes into late endosomes.\",\n      \"method\": \"siRNA depletion; in vivo and in vitro endosome fusion assays; fluorescence microscopy of endosomal markers\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with specific endosomal phenotypes (fragmentation of APPL1 endosomes, accumulation of EEA1 endosomes) confirmed in vivo and in vitro\",\n      \"pmids\": [\"25266290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TGFBRAP1 plays a critical role in chitinase 1 (CHIT1) enhancement of TGF-β1 signaling and fibrotic responses. CHIT1 physically interacts with TGFBRAP1, and TGFBRAP1 is required for CHIT1-mediated enhancement of TGF-β1 downstream effector responses and inhibition of the TGF-β1 feedback inhibitor SMAD7, as demonstrated in pulmonary fibrosis models.\",\n      \"method\": \"Co-immunoprecipitation (CHIT1–TGFBRAP1 interaction); siRNA knockdown of TGFBRAP1 with TGF-β signaling readouts; fibrotic cellular and tissue assays\",\n      \"journal\": \"Life science alliance\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP and loss-of-function with defined signaling readout (SMAD7 suppression), single lab\",\n      \"pmids\": [\"31085559\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TGFBRAP1 is a cytoplasmic protein that functions as a molecular chaperone for Smad4 in TGF-β signaling—binding inactive TGF-β receptor complexes, releasing upon activation, and facilitating Smad4 transfer to receptor-activated Smads—and also serves as the mammalian CORVET tethering complex subunit orthologous to yeast Vps3, where it interacts directly with Rab5-GTP on early endosomes, is selected by VPS11 to direct CORVET (versus HOPS) to early endosomes, and is required for fusion and maturation of distinct early endosome subpopulations.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TRAP1 is a mitochondrial Hsp90-family chaperone that functions as a central regulator of mitochondrial proteostasis, bioenergetics, and cell survival through an ATP-dependent conformational cycle modulated by a unique N-terminal strap, calcium/magnesium cofactor switching, and post-translational modifications including PINK1 phosphorylation, ERK1/2 phosphorylation, and S-nitrosylation at Cys501 [PMID:10652318, PMID:25531069, PMID:29991590, PMID:17579517, PMID:28099845, PMID:32088262]. TRAP1 controls the balance between oxidative phosphorylation and glycolysis by interacting with and stabilizing key metabolic clients—succinate dehydrogenase, phosphofructokinase-1, complex III subunit UQCRC2, and F-ATP synthase OSCP subunit—while also inhibiting the mitochondrial permeability transition pore by competing with cyclophilin D for OSCP binding [PMID:23564345, PMID:33025742, PMID:36510251, PMID:35614131, PMID:28099845]. Beyond mitochondria, TRAP1 operates at the endoplasmic reticulum with the proteasomal ATPase TBP7 to regulate ubiquitination of mitochondria-destined proteins, protects mitochondrial cristae by shielding MIC60 from MARCH5-mediated ubiquitination, and maintains mitochondrial fission/fusion balance through stabilization of Drp1 and Mff [PMID:21979464, PMID:37679468, PMID:23284813]. A loss-of-function TRAP1 mutation has been identified in a Parkinson's disease patient, consistent with TRAP1 operating downstream of PINK1 in a mitochondrial quality-control pathway whose disruption causes dopaminergic neurodegeneration [PMID:29050400, PMID:23525905].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing TRAP1 as a mitochondrial Hsp90-family ATPase that, despite structural homology, is functionally distinct from cytosolic Hsp90 resolved a key question about whether Hsp90 paralogs partition into separate chaperone networks.\",\n      \"evidence\": \"Immunofluorescence localization, in vitro ATPase assay with geldanamycin/radicicol inhibition, failure to bind Hsp90 co-chaperones or reconstitute progesterone receptor\",\n      \"pmids\": [\"10652318\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No client proteins identified\", \"Physiological function in mitochondria unknown\", \"Oligomeric state not determined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identifying PINK1 as a kinase that directly phosphorylates TRAP1 to prevent oxidative-stress-induced cytochrome c release connected TRAP1 to Parkinson's disease-linked mitochondrial quality control and established its first upstream regulatory axis.\",\n      \"evidence\": \"In vitro kinase assay, co-IP, colocalization, cell death assays with PD-linked PINK1 mutants (G309D, L347P, W437X)\",\n      \"pmids\": [\"17579517\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation site(s) on TRAP1 not mapped\", \"Downstream mechanism of cytoprotection unclear\", \"In vivo validation in animal PD models lacking\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Kinetic dissection of the TRAP1 ATPase cycle revealed that hydrolysis, not conformational closure, is rate-limiting, establishing the enzymological framework for understanding how cofactors and PTMs tune chaperone activity.\",\n      \"evidence\": \"Rapid kinetic methods with global fitting; two-step ATP binding, irreversible hydrolysis (k_hyd = 0.0039 s⁻¹), one-step ADP release\",\n      \"pmids\": [\"18287101\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How client binding modulates ATPase cycle unknown\", \"No structural basis for rate-limiting step\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery that TRAP1 and the calcium-binding protein Sorcin reciprocally stabilize each other in mitochondria identified the first bona fide TRAP1 client relationship and suggested a proteostatic stabilization function.\",\n      \"evidence\": \"Proteomic co-IP/MS, reciprocal knockdown showing mutual destabilization, mitochondrial fractionation\",\n      \"pmids\": [\"20647321\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Sorcin is a chaperone client or a co-chaperone not distinguished\", \"Functional consequence for mitochondrial calcium handling not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Finding that TRAP1 operates at the ER with the proteasomal ATPase TBP7 to control ubiquitination of mitochondria-destined proteins expanded TRAP1 function beyond the mitochondrial matrix to an ER quality-control checkpoint.\",\n      \"evidence\": \"FRET-validated TRAP1-TBP7 interaction at ER, electron microscopy localization, ubiquitination assays upon TRAP1 silencing\",\n      \"pmids\": [\"21979464\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of specific mitochondria-destined client proteins regulated at ER not determined\", \"Mechanism of TRAP1 dual localization (ER vs mitochondria) unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Genetic epistasis in Drosophila placed TRAP1 downstream of PINK1 and parallel to Parkin, and showed TRAP1 rescues α-Synuclein-induced Complex I deficiency and mitochondrial fragmentation, solidifying its role in the PD-linked mitochondrial pathway.\",\n      \"evidence\": \"Drosophila PINK1/Parkin loss-of-function rescue by human TRAP1 overexpression, Complex I activity assay, mitochondrial morphology\",\n      \"pmids\": [\"23525905\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise substrates mediating Complex I rescue unknown\", \"Whether TRAP1 directly chaperones Complex I subunits not shown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Metabolic profiling of TRAP1-null cells revealed that TRAP1 suppresses oxidative phosphorylation and promotes the glycolytic shift through interaction with mitochondrial c-Src, establishing TRAP1 as a metabolic switch rather than merely a stress-responsive chaperone.\",\n      \"evidence\": \"TRAP1-null cells, metabolic flux analysis showing increased respiration/FAO/ROS, co-IP with c-Src\",\n      \"pmids\": [\"23564345\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How c-Src interaction mechanistically suppresses OXPHOS not resolved\", \"Relative contribution of multiple TRAP1 clients to metabolic phenotype unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Crystal structures of TRAP1 revealed a unique N-terminal strap that stabilizes the closed ATP-bound dimer via trans-protomer contacts and creates a temperature-sensitive kinetic barrier, explaining TRAP1's distinctive ATPase regulation and providing the first structural framework for inhibitor design.\",\n      \"evidence\": \"X-ray crystallography of TRAP1-inhibitor and TRAP1-AMP-PNP complexes, strap mutagenesis with ATPase kinetics\",\n      \"pmids\": [\"25531069\", \"25785725\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No client-bound structure available\", \"Structural basis for how PTMs modulate strap dynamics unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"TRAP1 knockout mice showed reduced age-associated pathology with deregulated OXPHOS/glycolysis transcriptomes, providing in vivo mammalian validation that TRAP1 is a central bioenergetic regulator.\",\n      \"evidence\": \"TRAP1 knockout mouse, transcriptome and metabolic analysis\",\n      \"pmids\": [\"25088416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type-specific contributions not dissected\", \"Whether reduced pathology reflects compensatory adaptation or direct TRAP1 effect unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating that ERK1/2 phosphorylates TRAP1 to enhance TRAP1-SDH complex formation and SDH inhibition in neurofibromin-deficient tumors linked oncogenic Ras-MAPK signaling to TRAP1-mediated metabolic reprogramming and identified specific phospho-serine residues required for tumorigenicity.\",\n      \"evidence\": \"Co-IP, in vitro phosphorylation, SDH activity, metabolomics, mutagenesis of ERK1/2-targeted serines abolishing tumorigenicity\",\n      \"pmids\": [\"28099845\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise ERK1/2 phosphorylation sites on TRAP1 not fully mapped\", \"Whether this axis operates outside neurofibromin-deficient contexts not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Structural identification of a calcium-binding site in the TRAP1 nucleotide pocket revealed that calcium switches TRAP1 hydrolysis from non-cooperative (Mg²⁺) to cooperative between protomers, providing a mechanism for mitochondrial calcium to directly tune chaperone function.\",\n      \"evidence\": \"Anomalous X-ray diffraction, ATPase kinetics with Ca²⁺/Mg²⁺ substitution\",\n      \"pmids\": [\"29991590\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological calcium concentrations in mitochondrial matrix may not sustain this mode\", \"Impact on client binding/release not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Multiple studies converged to show that S-nitrosylation at Cys501 inhibits TRAP1 ATPase activity and promotes its proteasomal degradation, while TRAP1 also stabilizes PFK1 to drive glycolysis—revealing how redox and metabolic signals fine-tune TRAP1 chaperone output.\",\n      \"evidence\": \"Site-directed mutagenesis (C501S), in vitro ATPase, MD simulation, co-IP of TRAP1-PFK1, ubiquitination assay\",\n      \"pmids\": [\"32088262\", \"27216192\", \"33025742\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts driving Cys501 S-nitrosylation in vivo not well defined\", \"Interplay between S-nitrosylation and other PTMs on same molecule unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of a TRAP1 tetramer whose levels respond to OXPHOS status, together with the finding that ATPase activity is dispensable for OXPHOS restoration but modulates the interaction network, refined the model of how TRAP1 oligomerization and enzymatic activity independently contribute to metabolic regulation.\",\n      \"evidence\": \"Native gel electrophoresis, quantitative interactome in multiple cell lines, ATPase-dead mutant rescue\",\n      \"pmids\": [\"31987035\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tetramer structure not resolved\", \"How tetramer-dimer equilibrium is regulated in vivo unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrating that TRAP1 binds the F-ATP synthase OSCP subunit in competition with cyclophilin D and directly inhibits PTP channel activity by electrophysiology of purified complexes established TRAP1 as a bona fide inhibitor of the mitochondrial permeability transition pore.\",\n      \"evidence\": \"Co-IP, competitive binding, electrophysiology of purified F-ATP synthase, cell death assays\",\n      \"pmids\": [\"35614131\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TRAP1-OSCP interaction is regulated by TRAP1 PTMs not tested\", \"Stoichiometry of TRAP1 on F-ATP synthase unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showing that TRAP1 competitively blocks MARCH5-mediated K48-linked ubiquitination of MIC60 at Lys285 to preserve cristae architecture identified a specific client-protection mechanism linking TRAP1 chaperone function to mitochondrial ultrastructure maintenance.\",\n      \"evidence\": \"Competitive co-IP (TRAP1-MIC60-MARCH5), K285R mutagenesis, cristae morphology, cardiomyocyte apoptosis under diabetic stress\",\n      \"pmids\": [\"37679468\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other TRAP1 clients are similarly protected from MARCH5 unknown\", \"Structural basis of TRAP1-MIC60 interaction not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"In vivo VSMC-specific TRAP1 knockout showed that TRAP1-driven glycolysis produces lactate that reduces HDAC3 and promotes H4K12 lactylation at SASP gene promoters, establishing a new epigenetic link from mitochondrial chaperone activity to vascular cell senescence and atherosclerosis.\",\n      \"evidence\": \"VSMC-specific Trap1 KO in ApoE-null mice, ChIP for H4K12la, metabolic assays, PROTAC degradation\",\n      \"pmids\": [\"39088352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether lactylation-mediated senescence is generalizable beyond VSMCs unknown\", \"Direct TRAP1 client mediating glycolytic shift in VSMCs not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include the structural basis of TRAP1–client recognition, how the tetramer-dimer equilibrium is physiologically regulated, the full spectrum of TRAP1 clients across tissues, and whether TRAP1's ER and endosomal functions represent quantitatively important pools in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No client-bound TRAP1 structure exists\", \"Tetramer regulation mechanism unknown\", \"Tissue-specific client repertoire not systematically mapped\", \"ER/endosomal TRAP1 pool significance relative to mitochondrial pool unclear\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 3, 11, 18, 20]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [4, 8, 21, 24, 26]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [8, 16, 24, 26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 4, 8, 16, 19, 24]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [5, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [8, 12, 16, 21, 27]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 2, 24, 26]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [5, 9, 13]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [2, 6, 34]}\n    ],\n    \"complexes\": [\n      \"TRAP1 homodimer/tetramer\"\n    ],\n    \"partners\": [\n      \"PINK1\",\n      \"SDH\",\n      \"OSCP\",\n      \"TBP7\",\n      \"Sorcin\",\n      \"MIC60\",\n      \"CDK1\",\n      \"UQCRC2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"TGFBRAP1 is a bifunctional cytoplasmic protein that operates both as a molecular chaperone in TGF-β/activin signaling and as a subunit of the mammalian CORVET endosomal tethering complex. In the TGF-β pathway, TGFBRAP1 associates with inactive heteromeric TGF-β receptor complexes, is released upon ligand-induced receptor activation, and escorts Smad4 to the activated receptor to facilitate its transfer to receptor-activated Smads such as Smad2 [PMID:9545258, PMID:11278302]. As the mammalian ortholog of yeast Vps3, TGFBRAP1 binds Rab5-GTP directly and is incorporated into the CORVET complex via VPS11, which acts as a molecular switch selecting TGFBRAP1 (CORVET) versus VPS39 (HOPS) to direct tethering to early versus late endosomes; depletion of TGFBRAP1 causes fragmentation of APPL1-positive early endosomes and impaired maturation of EEA1-positive endosomes [PMID:25266290, PMID:26463206]. Homozygous knockout in mice results in embryonic lethality before the blastula stage or during gastrulation, demonstrating a non-redundant developmental requirement [PMID:20961651].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"The initial discovery that TGFBRAP1 physically associates with the activated TGF-β type I receptor established it as a novel component of TGF-β signaling and showed that a dominant-negative fragment could inhibit pathway output.\",\n      \"evidence\": \"Yeast two-hybrid with constitutively active TβR-I bait; mammalian co-immunoprecipitation; TGF-β reporter assay\",\n      \"pmids\": [\"9545258\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which TGFBRAP1 modulates receptor signaling was unknown\",\n        \"No downstream effectors (Smads) yet linked to TGFBRAP1\",\n        \"In vivo relevance not tested\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrating that TGFBRAP1 functions as a Smad4 chaperone—associating with inactive receptors, releasing upon activation, and escorting Smad4 to receptor-activated Smads—resolved how it promotes signal transduction rather than merely associating with receptors.\",\n      \"evidence\": \"Co-immunoprecipitation; FRET; deletion mutant analysis; TGF-β reporter assays in mammalian cells\",\n      \"pmids\": [\"11278302\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of the TGFBRAP1–Smad4 interaction unknown\",\n        \"Whether TGFBRAP1 is required for activin versus TGF-β signaling equally was not resolved\",\n        \"No in vivo loss-of-function data\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The finding that homozygous Tgfbrap1 knockout causes embryonic lethality at pre-blastula and gastrulation stages established a non-redundant in vivo requirement, consistent with its role in TGF-β superfamily signaling during early development.\",\n      \"evidence\": \"Gene knockout mouse model with embryonic lethality phenotyping\",\n      \"pmids\": [\"20961651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which signaling pathway(s) account for each lethal time point was not determined\",\n        \"Tissue-specific or conditional knockouts not reported\",\n        \"Endosomal trafficking role in embryonic lethality not assessed\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of TGFBRAP1 as the mammalian CORVET-specific subunit (Vps3 ortholog) that directly binds Rab5-GTP, and the demonstration that VPS11 selects TGFBRAP1 versus VPS39 to target CORVET to early endosomes, revealed an unexpected second function in endosomal tethering and explained how early and late endosome fusion events are separately controlled.\",\n      \"evidence\": \"In vitro Rab5-GTP binding; confocal co-localization; affinity-purification and co-IP of CORVET/HOPS subunits; siRNA depletion with endosomal marker analysis; in vivo and in vitro endosome fusion assays\",\n      \"pmids\": [\"25750764\", \"26463206\", \"25266290\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of VPS11's selectivity for TGFBRAP1 versus VPS39 unresolved\",\n        \"Whether the TGF-β chaperone and CORVET functions are mutually exclusive or coordinated is unknown\",\n        \"Yeast complementation by mammalian TGFBRAP1 was negative, leaving open whether the Vps3 orthology is complete\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"The finding that chitinase 1 physically interacts with TGFBRAP1 and requires it for enhancement of TGF-β1 signaling and suppression of the feedback inhibitor SMAD7 extended the chaperone function to a pathological fibrotic context.\",\n      \"evidence\": \"Co-immunoprecipitation of CHIT1–TGFBRAP1; siRNA knockdown with TGF-β signaling readouts in pulmonary fibrosis models\",\n      \"pmids\": [\"31085559\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which CHIT1 engagement of TGFBRAP1 enhances Smad4 delivery is unknown\",\n        \"In vivo confirmation in fibrosis models with genetic TGFBRAP1 ablation not reported\",\n        \"Whether this interaction is relevant beyond pulmonary fibrosis is untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A central unresolved question is how the dual roles of TGFBRAP1—as a TGF-β/Smad4 chaperone and a CORVET tethering subunit—are coordinated, whether they are functionally interdependent, and which function accounts for the embryonic lethality of the knockout.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural data for TGFBRAP1 in either complex\",\n        \"Conditional or tissue-specific loss-of-function studies not available\",\n        \"Relative contributions of TGF-β chaperone versus CORVET function to physiology are unresolved\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2, 7]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [4, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 7]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [4, 5, 6]}\n    ],\n    \"complexes\": [\n      \"CORVET\"\n    ],\n    \"partners\": [\n      \"TGFBR1\",\n      \"SMAD4\",\n      \"RAB5\",\n      \"VPS11\",\n      \"CHIT1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}